The U.S. Food and Drug Administration on Tuesday classified the recall of Medtronic's embolization device as "most serious", ...
The recall, which affects two models of Pipeline Vantage embolization devices, is linked to 17 injuries and four deaths.
The disruption is expected to impact patient care, may require adjustments to the management of hemodialysis patients and ...
Most medical devices in the United States come to market with limited clinical data, and device surveillance is viewed as a ...
Almost a third of medical device adverse events (AEs) were reported by manufacturers later than the US Food and Drug Administration’s (FDA) required 30-day window across a three-year period ...
Dexcom, a medical device manufacturer that develops continuous glucose monitoring systems, received a warning letter from the FDA regarding manufacturing processes at its facilities in San Diego and ...
More than 1.2 million medical device adverse event reports were not submitted to the US Food and Drug Administration (FDA) ...
The U.S. Food and Drug Administration said on Friday that supply interruptions of hemodialysis bloodlines, a key component in ...
Medtronic will remove one model of Pipeline Vantage devices from where they’re used and sold and will update the instructions ...
March 18 (Reuters) - The U.S. Food and Drug Administration on Tuesday classified ... reported injuries associated with the use of devices known as Pipeline Vantage Embolization devices.